WallStreetZenWallStreetZen

NASDAQ: BBIO
Bridgebio Pharma Inc Stock Ownership - Who owns Bridgebio Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bridgebio Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Maricel ApuliCAO2026-07-302,000$80.06
$160.12kSell
Jennifer E. CookDirector2026-07-0936,167$84.00
$3.04MSell
Jennifer E. CookDirector2026-07-0917,167$16.75
$287.55kBuy
Andrea EllisDirector2026-07-0917,167$84.00
$1.44MSell
Andrea EllisDirector2026-07-0917,167$16.75
$287.55kBuy
Jennifer E. CookDirector2026-07-09112,422$90.00
$10.12MSell
Jennifer E. CookDirector2026-07-0919,000$8.45
$160.55kBuy
Jennifer E. CookDirector2026-07-09112,422$29.00
$3.26MBuy
Jennifer E. CookDirector2026-06-2437,167$70.00
$2.60MSell
Jennifer E. CookDirector2026-06-2420,000$8.45
$169.00kBuy

1 of 21

BBIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BBIO insiders and whales buy or sell their stock.

BBIO Shareholders

What type of owners hold Bridgebio Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kkr Group Partnership LP18.84%36,900,661$3.12BInsider
Viking Global Performance LLC13.59%26,620,991$2.25BInsider
Viking Global Investors LP9.47%18,555,375$1.57BInsider
Blackrock Inc7.25%14,207,757$1.20BInstitution
Kohlberg Kravis Roberts Co LP6.77%13,260,971$1.12BInstitution
Kkr Genetic Disorder LP6.77%13,260,971$1.12BInsider
Janus Henderson Group PLC6.73%13,179,013$1.12BInstitution
Viking Global Investors LP6.05%11,842,434$1.00BInstitution
Farallon Capital Management LLC4.78%9,365,463$792.97MInstitution
Vanguard Portfolio Management LLC4.13%8,080,573$684.18MInstitution

1 of 3

BBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BBIO64.70%35.30%Net SellingNet Selling
JAZZ29.87%70.13%Net SellingNet Selling
ASND99.19%0.81%Net SellingNet Buying
GMAB100.00%0.00%
BMRN94.86%1.81%Net SellingNet Selling
View Top Biotech Stocks

Bridgebio Pharma Stock Ownership FAQ

Who owns Bridgebio Pharma?

Bridgebio Pharma (NASDAQ: BBIO) is owned by 99.38% institutional shareholders, 54.23% Bridgebio Pharma insiders, and 0.00% retail investors. Kkr Group Partnership LP is the largest individual Bridgebio Pharma shareholder, owning 36.90M shares representing 18.84% of the company. Kkr Group Partnership LP's Bridgebio Pharma shares are currently valued at $3.09B.

If you're new to stock investing, here's how to buy Bridgebio Pharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.